MitoQ (Mitoquinone) mesylate

Catalog No.S8978 Batch:S897803

Print

Technical Data

Formula

C38H47O7PS
Molecular Weight 678.81 CAS No. 845959-50-4
Solubility (25°C)* In vitro DMSO 50 mg/mL (73.65 mM)
Water 9 mg/mL (13.25 mM)
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
2.0mg/ml Taking the 1 mL working solution as an example, add 50 μL of 40 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to make it clear; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description MitoQ (Mitoquinone) mesylate is a TPP-based, mitochondria-targeted antioxidant that blocks H2O2-induced intracellular ROS responses and protects against oxidative damage. This product is a waxy solid.
Targets
mitochondria [1] ROS [1]
In vitro

Mitoquinone blocks H2O2-induced intracellular ROS responses inmurine pancreatic acinar cells. Mitoquinone does not reduce mitochondrial depolarisation induced by either cholecystokinin (CCK) or bile acid TLCS. Mitoquinone increases basal and CCK-induced cell death in a plate-reader assay.[1]
In vivo

In a TLCS-induced AP model Mitoquinone treatment is not protective. In AP induced by caerulein hyperstimulation (CER-AP), Mitoquinone exerts mixed effects. Thus, partial amelioration of histopathology scores is observed but without reduction of the biochemical markers pancreatic trypsin or serumamylase. Lungmyeloperoxidase and interleukin-6 are concurrently increased by Mitoquinone in CER-AP. Mitoquinone causes biphasic effects on ROS production in isolated polymorphonuclear leukocytes, inhibiting an acute increase but elevating later levels.[1]

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    Pancreatic Acinar Cells

  • Concentrations

    1 μM, 10 μM

  • Incubation Time

    200 s, 400 s, 600 s, 800 s, 1000 s

  • Method

    The cells are loaded with 40 nM TMRM for 30 minutes prior incubation with either 1 μM or 10 μM of MitoQ or dTPP. Cholecystokinin-8 (CCK-8, 10 nM) or bile acid taurolithocholic acid 3-sulphate (TLCS, 500 μM) is used to induce ΔΨm depolarisation. At the end of the perfusion, the protonophore carbonyl cyanide 3-chlorophenylhydrazone (CCCP, 10 μM) is added to induce complete depolarisation of ΔΨm. The fluorescence of TMRM is excited at 543 nm and the emission is collected at 560–650 nm.
Animal Study:

[1]
  • Animal Models

    C57BL/6J mice

  • Dosages

    10 mg/kg, 25 mg/kg

  • Administration

    IP

Selleck's MitoQ (Mitoquinone) mesylate has been cited by 26 publications

Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury [ Circ Res, 2024, 134(10):1292-1305] PubMed: 38618716
Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury [ Circ Res, 2024, 134(10):1292-1305] PubMed: 38618716
Acidic preconditioning induced intracellular acid adaptation to protect renal injury via dynamic phosphorylation of focal adhesion kinase-dependent activation of sodium hydrogen exchanger 1 [ Cell Commun Signal, 2024, 22(1):393.] PubMed: 39118129
Tert promotes cardiac regenerative repair after MI through alleviating ROS-induced DNA damage response in cardiomyocyte [ Cell Death Discov, 2024, 10(1):381] PubMed: 39187478
Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells [ Int J Mol Sci, 2024, 25(9)4923] PubMed: 38732133
SBDS Gene Mutation Increases ROS Production and Causes DNA Damage as Well as Oxidation of Mitochondrial Membranes in the Murine Myeloid Cell Line 32Dcl3 [ Biol Pharm Bull, 2024, 47(7):1376-1382] PubMed: 39085077
Local production of reactive oxygen species drives vincristine-induced axon degeneration [ Cell Death Dis, 2023, 14(12):807] PubMed: 38065950
O-GlcNAcylation Is Required for the Survival of Cerebellar Purkinje Cells by Inhibiting ROS Generation [ Antioxidants (Basel), 2023, 12(4)806] PubMed: 37107182
Mitoquinone alleviates osteoarthritis progress by activating the NRF2-Parkin axis [ iScience, 2023, 26(9):107647] PubMed: 37694150
MitoQ Protects Ovarian Organoids against Oxidative Stress during Oogenesis and Folliculogenesis In Vitro [ Int J Mol Sci, 2023, 24(2)924] PubMed: 36674435

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.